An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia

• Main Authors: Bee, P.C., Gan, G.G., Tai, Y.T., Haris, A.R., Chin, E., Veera, S.N.
• Format: Article
• Published: 2012
• Subjects: R Medicine
• Online Access: http://eprints.um.edu.my/2983/; http://www.ncbi.nlm.nih.gov/pubmed/22252185

INTRODUCTION: The introduction of imatinib mesylate in 1998 has changed the management of chronic myeloid leukaemia. It is now the first-line therapy for newly diagnosed chronic myeloid leukaemia patients worldwide. However, its long-term survival benefit still needs to be established in clinical s...